CAMP4 Therapeutics
CAMP
36 hedge funds and large institutions have $67.1M invested in CAMP4 Therapeutics in 2024 Q4 according to their latest regulatory filings, with 36 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
63.76% more ownership
Funds ownership: 0% → 63.76% (+64%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
5VM
5AM Venture Management
San Francisco,
California
|
+$24.1M |
| 2 |
ACM
AH Capital Management
Menlo Park,
California
|
+$17.5M |
| 3 |
HP
Harbourvest Partners
Boston,
Massachusetts
|
+$10.4M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.2M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$5.22M |
Top Sellers
CAMP Hedge Fund Activity: Q4 2024 in Review
36 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in CAMP4 Therapeutics (CAMP) for Q4 2024, worth a combined $67.1M.
Buyers outnumbered sellers: 36 funds opened new CAMP positions and 0 closed out — a net gain of 36 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was 5AM Venture Management, opening a new position worth an estimated $24.1M.
- 36 institutional investors held CAMP4 Therapeutics (CAMP) as of Q4 2024, up from 0 in Q3 2024.
- Funds reported $67.1M of CAMP4 Therapeutics stock for Q4 2024.
- 36 funds opened new CAMP4 Therapeutics positions in Q4 2024 and 0 closed out, a net change of +36 holders.
- The largest CAMP4 Therapeutics buyer in Q4 2024 was 5AM Venture Management, an estimated $24.1M added.
Based on aggregated 13F filings for Q4 2024.